Cargando…
SARS-CoV-2 vaccines for cancer patients treated with immunotherapies: Recommendations from the French society for ImmunoTherapy of Cancer (FITC)
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891073/ https://www.ncbi.nlm.nih.gov/pubmed/33743480 http://dx.doi.org/10.1016/j.ejca.2021.02.003 |
| _version_ | 1783652628941504512 |
|---|---|
| author | Gauci, Marie-Léa Coutzac, Clélia Houot, Roch Marabelle, Aurélien Lebbé, Céleste |
| author_facet | Gauci, Marie-Léa Coutzac, Clélia Houot, Roch Marabelle, Aurélien Lebbé, Céleste |
| author_sort | Gauci, Marie-Léa |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7891073 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78910732021-02-19 SARS-CoV-2 vaccines for cancer patients treated with immunotherapies: Recommendations from the French society for ImmunoTherapy of Cancer (FITC) Gauci, Marie-Léa Coutzac, Clélia Houot, Roch Marabelle, Aurélien Lebbé, Céleste Eur J Cancer Letter to the Editor Elsevier Ltd. 2021-05 2021-02-18 /pmc/articles/PMC7891073/ /pubmed/33743480 http://dx.doi.org/10.1016/j.ejca.2021.02.003 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Gauci, Marie-Léa Coutzac, Clélia Houot, Roch Marabelle, Aurélien Lebbé, Céleste SARS-CoV-2 vaccines for cancer patients treated with immunotherapies: Recommendations from the French society for ImmunoTherapy of Cancer (FITC) |
| title | SARS-CoV-2 vaccines for cancer patients treated with immunotherapies: Recommendations from the French society for ImmunoTherapy of Cancer (FITC) |
| title_full | SARS-CoV-2 vaccines for cancer patients treated with immunotherapies: Recommendations from the French society for ImmunoTherapy of Cancer (FITC) |
| title_fullStr | SARS-CoV-2 vaccines for cancer patients treated with immunotherapies: Recommendations from the French society for ImmunoTherapy of Cancer (FITC) |
| title_full_unstemmed | SARS-CoV-2 vaccines for cancer patients treated with immunotherapies: Recommendations from the French society for ImmunoTherapy of Cancer (FITC) |
| title_short | SARS-CoV-2 vaccines for cancer patients treated with immunotherapies: Recommendations from the French society for ImmunoTherapy of Cancer (FITC) |
| title_sort | sars-cov-2 vaccines for cancer patients treated with immunotherapies: recommendations from the french society for immunotherapy of cancer (fitc) |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891073/ https://www.ncbi.nlm.nih.gov/pubmed/33743480 http://dx.doi.org/10.1016/j.ejca.2021.02.003 |
| work_keys_str_mv | AT gaucimarielea sarscov2vaccinesforcancerpatientstreatedwithimmunotherapiesrecommendationsfromthefrenchsocietyforimmunotherapyofcancerfitc AT coutzacclelia sarscov2vaccinesforcancerpatientstreatedwithimmunotherapiesrecommendationsfromthefrenchsocietyforimmunotherapyofcancerfitc AT houotroch sarscov2vaccinesforcancerpatientstreatedwithimmunotherapiesrecommendationsfromthefrenchsocietyforimmunotherapyofcancerfitc AT marabelleaurelien sarscov2vaccinesforcancerpatientstreatedwithimmunotherapiesrecommendationsfromthefrenchsocietyforimmunotherapyofcancerfitc AT lebbeceleste sarscov2vaccinesforcancerpatientstreatedwithimmunotherapiesrecommendationsfromthefrenchsocietyforimmunotherapyofcancerfitc AT sarscov2vaccinesforcancerpatientstreatedwithimmunotherapiesrecommendationsfromthefrenchsocietyforimmunotherapyofcancerfitc |